TGFB1 and familial pancreatic carcinoma: Elevated systemic levels of TGF-β have been reported in breast cancer, lung cancer, pancreatic cancer, glioblastoma multiforme, colorectal carcinoma, HCC, renal cell carcinoma, and gastric carcinoma (72).